Dr Sophie Rowlands

2025

• Barker, R. A. et al., 2025. The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.. Nature Biotechnology (10.1038/s41587-025-02567-2)
• Hakami, A. et al. 2025. Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death. Neurotherapeutics 22 (2) e00518. (10.1016/j.neurot.2024.e00518)

2020

• Precious, S. V. et al. 2020. Dopaminergic progenitors derived from epiblast stem cells function similarly to primary VM-derived progenitors when transplanted into a Parkinson’s disease model. Frontiers in Neuroscience 14 312. (10.3389/fnins.2020.00312)

2012

• Zietlow, R. et al. 2012. Long-term expansion of human foetal neural progenitors leads to reduced graft viability in the neonatal rat brain. Experimental Neurology 235 (2), pp.563-573. (10.1016/j.expneurol.2012.03.010)

2011

• Kelly, C. et al. 2011. Medical terminations of pregnancy: A viable source of tissue for cell replacement therapy for neurodegenerative disorders. Cell Transplantation 20 (4), pp.503-513. (10.3727/096368910X546580)

2009

• Kelly, C. M. et al. 2009. Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression. Nature Methods 6 (4), pp.271-273. (10.1038/nmeth.1308)

2007

• Amso, N. N. et al. 2007. Striatal graft projections are influenced by donor cell type and not the immunogenic background. Brain 130 (5), pp.1317-29. (10.1093/brain/awm053)
• Kelly, C. et al. 2007. Striatal graft projections are influencd by donor cell type and not the immunogenic background. Brain 130 , pp.1317-1329. (10.1093/brain/awm053)
• Kelly, C. et al. 2007. Striatal graft projections are influenced by donor cell type and not the immunogenic background. Brain 130 (5), pp.1317-1329. (10.1093/brain/awm053)